Madrigal Pharmaceuticals, Inc. (MDGL)
435.01
-1.86
(-0.43%)
USD |
NASDAQ |
Feb 20, 16:00
435.20
+0.19
(+0.04%)
After-Hours: 20:00
Madrigal Pharmaceuticals Profit Margin (Quarterly) : -18.24% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | -9.34% |
| Eli Lilly & Co. | 34.40% |
| Insmed, Inc. | -124.5% |
| Johnson & Johnson | 20.83% |
| Crinetics Pharmaceuticals, Inc. | -90.97K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.53% |
| Return on Assets | -25.39% |
| Return on Invested Capital | -32.42% |
| Gross Profit Margin (Quarterly) | 92.26% |
| Operating Margin (Quarterly) | -18.56% |
| Return on Net Operating Assets | -180.4% |